Template:Syphilis: Difference between revisions

Jump to navigation Jump to search
Aditya Govindavarjhulla (talk | contribs)
No edit summary
Tarek Nafee (talk | contribs)
No edit summary
 
(20 intermediate revisions by 4 users not shown)
Line 1: Line 1:
{| class="infobox bordered" style="width: 15em; text-align: left; font-size: 90%; background:AliceBlue"
{| class="infobox bordered" style="width: 15em; text-align: left; font-size: 90%; background:AliceBlue"
|- bgcolor="LightGrey"
!
[[Sexually transmitted disease|'''Sexually transmitted diseases Main Page''']]
|-
!
|-
|-
| colspan="1" style="text-align:center; background:DarkGray" |
| colspan="1" style="text-align:center; background:DarkGray" |
Line 8: Line 15:
!
!


!
|- bgcolor="LightCoral"
|- bgcolor="LightCoral"
!
!
Line 28: Line 36:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Syphilis classification|Classification]]
[[Syphilis historical perspective|Historical Perspective]]
*[[Congenital Syphilis]]
*[[Syphilis pathophysiology#Pathophysiology: Acquired syphilis|Acquired Syphilis]]
*[[Neurosyphilis]]
|-  
|-  
!
!
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Syphilis historical perspective|Historical Perspective]]
[[Syphilis classification|Classification]]
|-  
|-  
!
!
Line 44: Line 48:
!
!
[[Syphilis pathophysiology|Pathophysiology]]
[[Syphilis pathophysiology|Pathophysiology]]
*[[Syphilis pathophysiology#Primary syphilis|Primary]]
*[[Syphilis pathophysiology#Secondary syphilis|Secondary]]
*[[Syphilis pathophysiology#Latent syphilis|Latent]]
*[[Syphilis pathophysiology#Tertiary syphilis|Tertiary:]]
::*[[Syphilitic Aortitis]]
::*[[Tabes Dorsalis]]
|-  
|-  
!
!
Line 55: Line 53:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Syphilis causes|Causes]]
[[Treponema Pallidum|Causes]]
|-  
|-  
!
!
Line 64: Line 62:
|-  
|-  
!
!
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
Line 85: Line 82:
|- bgcolor="Pink"
|- bgcolor="Pink"
!
!
[[Syphilis natural history|Natural History, Complications and Prognosis]]
[[Syphilis natural history, complications and prognosis|Natural History, Complications and Prognosis]]
|-  
|-  
!
!
Line 97: Line 94:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Syphilis history and symptoms|History and Symptoms:]]
[[Syphilis history and symptoms|History and Symptoms]]
: [[Syphilis history and symptoms#Primary syphilis|Primary Syphilis]]
: [[Syphilis history and symptoms#Secondary syphilis|Secondary Syphilis]]
: [[Syphilis history and symptoms#Latent syphilis|Latent Syphilis]]
: [[Syphilis history and symptoms#Tertiary syphilis|Tertiary Syphilis]]
|-  
|-  
!
!
Line 107: Line 100:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Syphilis physical examination|Physical Examination:]]
[[Syphilis physical examination|Physical Examination]]
: [[Syphilis physical examination#Primary syphilis: Chancre|Chancre]]
: [[Syphilis physical examination#Secondary syphilis: Condylomata Lata|Condylomata lata]]
: [[Syphilis physical examination#Tertiary syphilis: Gumma|Gumma]]
|-  
|-  
!
!
Line 116: Line 106:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Syphilis laboratory tests#Serology|Serology:]]
[[Syphilis laboratory findings|Laboratory Findings]]
: [[Syphilis laboratory tests#Nontreponemal test|Non-treponemal Test]]
: [[Syphilis laboratory tests#Treponemal test|Treponemal Test]]
: [[Syphilis laboratory tests#Immunoassay|Immunoassay]]
|-  
|-  
!
!
Line 125: Line 112:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Syphilis laboratory tests#Dark field microscopy|Dark Field Microscopy]]
[[Syphilis x ray|X Ray]]
|-  
|-  
!
!
Line 131: Line 118:
|- bgcolor="LightSkyBlue"
|- bgcolor="LightSkyBlue"
!
!
[[Syphilis laboratory tests#CSF analysis|CSF Analysis]]
[[Syphilis CT|CT]]
|-
!
 
|- bgcolor="LightSkyBlue"
!
[[Syphilis MRI|MRI]]
|-
!
 
|- bgcolor="LightSkyBlue"
!
[[Syphilis ultrasound|Ultrasound]]
|-
!
 
|- bgcolor="LightSkyBlue"
!
[[Syphilis other imaging findings|Other Imaging Findings]]
|-
!
 
|- bgcolor="LightSkyBlue"
!
[[Syphilis other diagnostic studies|Other Diagnostic Studies]]
|-  
|-  
!
!
Line 143: Line 154:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
Pharmacotherapy:
[[Syphilis medical therapy|Medical Therapy]]
: [[Syphilis medical therapy#Pharmacotherapy|Pencillin G therapy]]  
:[[Syphilis management for primary and secondary stages|Primary and Secondary Syphilis]]
: [[Syphilis medical therapy#Pencillin allergy|Pencillin allergy]]  
:[[Syphilis management for latent stage|Latent Syphilis]]
: [[Syphilis medical therapy#Jarisch-Herxheimer reaction|Jarisch-Herxheimer Reaction]]
:[[Syphilis management for tertiary stage|Tertiary Syphilis]]
:[[Syphilis management for neurosyphilis|Neurosyphilis]]
:[[Syphilis management among HIV-infected persons|HIV-Infected Patients]]
:[[Syphilis management during pregnancy|Pregnancy]]
:[[Syphilis management of sexual partners|Management of Sexual Partners]]
|-  
|-  
!
!
Line 152: Line 167:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
Management based on stages:
[[Syphilis primary prevention|Primary Prevention]]
: [[Syphilis management for primary and secondary stages|Primary and Secondary Syphilis]]
|-
: [[Syphilis management for latent stage|Latent Syphilis]]
!
: [[Syphilis management for tertiary stage|Tertiary Syphilis]]
 
: [[Neurosyphilis]]
|- bgcolor="PaleTurquoise"
!
[[Syphilis secondary prevention|Secondary Prevention]]
|-  
|-  
!
|- bgcolor="PaleTurquoise"
!
[[Syphilis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]]
|-
!
!


|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
Specific population:
[[Syphilis future or investigational therapies|Future or Investigational Therapies]]
: [[Syphilis management among HIV-infected persons|HIV-infected Patients]]
|-
: [[Syphilis management during pregnancy|Pregnancy]]
!
: [[Syphilis management of sexual partners|Management of Sexual Partners]]
 
|- bgcolor="CadetBlue"
!
Case Studies
|-  
|-  
!
!
Line 171: Line 197:
|- bgcolor="PaleTurquoise"
|- bgcolor="PaleTurquoise"
!
!
Prevention:
[[Syphilis case study one|Case #1]]
: [[Syphilis primary prevention|Primary Prevention]]
: [[Syphilis secondary prevention|Secondary Prevention]]
|-  
|-  
!  
!
 
|- bgcolor="PaleGoldenrod "
|- bgcolor="PaleGoldenrod "
!
!
Line 268: Line 291:
|- bgcolor="LightYellow"
|- bgcolor="LightYellow"
!
!
[http://blogsearch.google.com/blogsearch?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&ie=UTF-8&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&sa=N&tab=wb Blogs on {{PAGENAME}}]</small>
[http://blogsearch.google.com/blogsearch?q={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}}&ie=UTF-8&oe=utf-8&rls=org.mozilla:en-US:official&client=firefox-a&um=1&sa=N&tab=wb Blogs on {{PAGENAME}}]
|-  
|-  
!  
!  

Latest revision as of 14:53, 30 March 2017